Pharmacokinetic and pharmacodynamic analysis of fulvestrant in preclinical models of breast cancer to assess the importance of its estrogen receptor-α degrader activity in antitumor efficacy
2019 · Breast Cancer Research and Treatment · 50 citations
https://doi.org/10.1007/s10549-019-05454-y